NewsBenzingaZoetis Exec Says New U.S. Dermatology Competitor Has Had Limited Share Gains Due To Supply Challenges; Expects Third-To-/Fourth Quarter Revenue Decline In High Single-Digit Range, Partly Due To Third-quarter Promotional Activity Zoetis Exec Says New U.S. Dermatology Competitor Has Had Limited Share Gains Due To Supply Challenges; Expects Third-To-/Fourth Quarter Revenue Decline In High Single-Digit Range, Partly Due To Third-quarter Promotional Activity Benzinga 2026.11.05 14:22 (GMT+0) Open on Benzinga Other news Sky Plans Osero Upgrade to Connect Ethereum and Base Liquidity Layers, Adding Gauntlet USDC Vault CLARITY Act May Be Shelved Until 2028 as a Democratic Sweep of Congress Could Leave the Crypto Industry on the Back Foot Analysis: US Tech Stocks Hit by Selloff Wave as Democratic Sweep of Congress Raises AI Regulation Fears Live Nation Entertainment Stock Outlook: Is Wall Street Bullish or Bearish? Dan Ives Maintains Bullish Rating on CrowdStrike Stock Amid Tech Sector Selloff NextEra Energy vs. Duke Energy: Which Dividend Utility Wins the AI Power Boom?
CLARITY Act May Be Shelved Until 2028 as a Democratic Sweep of Congress Could Leave the Crypto Industry on the Back Foot
Analysis: US Tech Stocks Hit by Selloff Wave as Democratic Sweep of Congress Raises AI Regulation Fears
